Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,035
archived clinical trials in
Bipolar Disorder

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Galiz Research
mi
from
Miami Springs, FL
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Galiz Research
mi
from
Miami Springs, FL
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Atlanta Center for Medical Research
mi
from
Atlanta, GA
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Clinco, Inc.
mi
from
Terre Haute, IN
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Clinco, Inc.
mi
from
Terre Haute, IN
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Activ Med Practices & Research
mi
from
Haverhill, MA
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Activ Med Practices & Research
mi
from
Haverhill, MA
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Psych Care Consultants Research
mi
from
St. Louis, MO
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Psych Care Consultants Research
mi
from
St. Louis, MO
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Charak Clincial Research Center
mi
from
Garlield Heights, OH
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Charak Clincial Research Center
mi
from
Garlield Heights, OH
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Cutting Edge Research Group
mi
from
Oklahoma City, OK
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Suburban Research Associates
mi
from
Media, PA
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Lincoln Research
mi
from
Lincoln, RI
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Lincoln Research
mi
from
Lincoln, RI
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Psychoneuroendocrinology Research Group, Dept of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Psychoneuroendocrinology Research Group, Dept of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
R/D Clinical Research, Inc.
mi
from
Lake Jackson, TX
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
R/D Clinical Research, Inc.
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated:  8/6/2015
Clinica Privada de Salud Mental Santa Teresa de Avila
mi
from
Buenos Aires,
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Clinica Privada de Salud Mental Santa Teresa de Avila
mi
from
Buenos Aires,
Click here to add this to my saved trials
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Status: Enrolling
Updated:  8/21/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
Status: Enrolling
Updated: 8/21/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Decision-Making in Bipolar Disorder
Decision-Making in Bipolar Disorder
Status: Enrolling
Updated:  8/31/2015
Emory University Mood and Anxiety Disorders Program
mi
from
Atlanta, GA
Decision-Making in Bipolar Disorder
Decision-Making in Bipolar Disorder
Status: Enrolling
Updated: 8/31/2015
Emory University Mood and Anxiety Disorders Program
mi
from
Atlanta, GA
Click here to add this to my saved trials
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated:  9/4/2015
Individual homes of subjects
mi
from
Not Predetermined, CT
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated: 9/4/2015
Individual homes of subjects
mi
from
Not Predetermined, CT
Click here to add this to my saved trials
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated:  9/4/2015
Juvenile Bipolar Research Foundation
mi
from
Maplewood, NJ
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated: 9/4/2015
Juvenile Bipolar Research Foundation
mi
from
Maplewood, NJ
Click here to add this to my saved trials
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated:  9/4/2015
Individual homes of subjects
mi
from
Not Predetermined, NJ
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated: 9/4/2015
Individual homes of subjects
mi
from
Not Predetermined, NJ
Click here to add this to my saved trials
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated:  9/4/2015
Individual homes of subjects
mi
from
Not Predetermined, NY
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
Status: Enrolling
Updated: 9/4/2015
Individual homes of subjects
mi
from
Not Predetermined, NY
Click here to add this to my saved trials
Internet-Based Interventions for Bipolar Disorder
2/2-A Randomized Trial of Internet-Based Interventions for Bipolar Disorder
Status: Enrolling
Updated:  9/8/2015
VA Palo Alto Healthcare System
mi
from
Palo Alto, CA
Internet-Based Interventions for Bipolar Disorder
2/2-A Randomized Trial of Internet-Based Interventions for Bipolar Disorder
Status: Enrolling
Updated: 9/8/2015
VA Palo Alto Healthcare System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
NMDA Antagonists in Bipolar Depression
NMDA Antagonists in Bipolar Depression
Status: Enrolling
Updated:  9/28/2015
New York State Psychiatric Institute
mi
from
New York, NY
NMDA Antagonists in Bipolar Depression
NMDA Antagonists in Bipolar Depression
Status: Enrolling
Updated: 9/28/2015
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Gao Bipolar Spectrum Lithium/Quetiapine Study
Comparative Safety, Tolerability, and Effectiveness of Lithium Versus Quetiapine in Patients Across the Spectrum of Bipolar Disorder
Status: Enrolling
Updated:  10/1/2015
University Hospitals Case Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Gao Bipolar Spectrum Lithium/Quetiapine Study
Comparative Safety, Tolerability, and Effectiveness of Lithium Versus Quetiapine in Patients Across the Spectrum of Bipolar Disorder
Status: Enrolling
Updated: 10/1/2015
University Hospitals Case Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Click here to add this to my saved trials
Relapse Prevention for Bipolar Type-II Disorder
Relapse Prevention of Bipolar Type-II Disorder
Status: Enrolling
Updated:  10/2/2015
Depression Research Unit, Univ Penn
mi
from
Philadelphia, PA
Relapse Prevention for Bipolar Type-II Disorder
Relapse Prevention of Bipolar Type-II Disorder
Status: Enrolling
Updated: 10/2/2015
Depression Research Unit, Univ Penn
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Complex Dynamic Systems in Mood Disorders
Complex Dynamic Systems in Mood Disorders
Status: Enrolling
Updated:  10/5/2015
Bipolar Clinic and Research Program at Massachusetts General Hospital
mi
from
Boston, MA
Complex Dynamic Systems in Mood Disorders
Complex Dynamic Systems in Mood Disorders
Status: Enrolling
Updated: 10/5/2015
Bipolar Clinic and Research Program at Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Status: Enrolling
Updated:  10/6/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Status: Enrolling
Updated: 10/6/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Status: Enrolling
Updated:  10/21/2015
Northwestern University
mi
from
Chicago, IL
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
Status: Enrolling
Updated: 10/21/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
University of California-Davis, Imaging Research Center
mi
from
Sacramento, CA
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
University of California-Davis, Imaging Research Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Portland Identification and Early Referral Program
mi
from
Portland, ME
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Portland Identification and Early Referral Program
mi
from
Portland, ME
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Washtenaw County
mi
from
Ann Arbor, MI
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Washtenaw County
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
University of New Mexico
mi
from
Albuquerque, NM
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Zucker Hillside Hosptial
mi
from
Glen Oaks, NY
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Zucker Hillside Hosptial
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Mid-Valley Behavioral Care Network
mi
from
Salem, OR
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Mid-Valley Behavioral Care Network
mi
from
Salem, OR
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Kissimmee, FL
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Atlanta, GA
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Hoffman Estates, IL
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Cedarhurst, NY
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
Clinical Research Facility
mi
from
Austin, TX
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated:  10/28/2015
mi
from
Banfield,
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status: Enrolling
Updated: 10/28/2015
mi
from
Banfield,
Click here to add this to my saved trials
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar
Status: Enrolling
Updated:  11/4/2015
NPI
mi
from
Chicago, IL
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar
Status: Enrolling
Updated: 11/4/2015
NPI
mi
from
Chicago, IL
Click here to add this to my saved trials
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar
Status: Enrolling
Updated:  11/4/2015
Neuro Psychiatric Institute (NPI)
mi
from
Chicago, IL
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar
Status: Enrolling
Updated: 11/4/2015
Neuro Psychiatric Institute (NPI)
mi
from
Chicago, IL
Click here to add this to my saved trials
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar
Status: Enrolling
Updated:  11/4/2015
NPI, University of Illinois at Chicago
mi
from
Chicago, IL
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar
Status: Enrolling
Updated: 11/4/2015
NPI, University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness
"My Coach Connect": Pilot Under the Partnered Research Center for Quality Care, RHINO 2008-0132
Status: Enrolling
Updated:  11/5/2015
ROADS (Recovery, Opportunity, And Developing Skills)
mi
from
Long Beach, CA
My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness
"My Coach Connect": Pilot Under the Partnered Research Center for Quality Care, RHINO 2008-0132
Status: Enrolling
Updated: 11/5/2015
ROADS (Recovery, Opportunity, And Developing Skills)
mi
from
Long Beach, CA
Click here to add this to my saved trials
Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
Status: Enrolling
Updated:  11/11/2015
University of Utah
mi
from
Salt Lake City, UT
Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
Status: Enrolling
Updated: 11/11/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Status: Enrolling
Updated:  11/16/2015
Stanford/VA Palo Alto Mood Disorder Research Program
mi
from
Palo Alto, CA
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Status: Enrolling
Updated: 11/16/2015
Stanford/VA Palo Alto Mood Disorder Research Program
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
Status: Enrolling
Updated:  11/19/2015
VA Puget Sound Health Care System
mi
from
Tacoma and Seattle, WA
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
Status: Enrolling
Updated: 11/19/2015
VA Puget Sound Health Care System
mi
from
Tacoma and Seattle, WA
Click here to add this to my saved trials